Maspin and tumor metastasis

IUBMB Life

Volumn 58, Issue 1, 2006, Pages 25-29

  Chen, Emily I ^a   Yates III, John R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Maspin; Tumor metastasis; Tumor suppressor gene

Indexed keywords

CHYMOTRYPSIN; MASPIN; PROTEASOME; PROTEINASE;

ANGIOGENESIS; APOPTOSIS; CANCER CELL; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CELL ADHESION; CELL INVASION; CELL MOTILITY; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENE STRUCTURE; GENETIC MANIPULATION; HUMAN; IN VIVO STUDY; METASTASIS; PROTEIN INTERACTION; PROTEINASE INHIBITION; REVIEW; STRUCTURE ANALYSIS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CELL ADHESION; CELL MOVEMENT; GENES, TUMOR SUPPRESSOR; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN CONFORMATION; SERPINS;

EID: 33645097948     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540500531721     Document Type: Review

References (35)

1. Zou, Z., Anisowicz, A., Hendrix, M. J., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E., and Sager, R. (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263, 526-529.
2. Hojo, T., Akiyama, Y., Nagasaki, K., Maruyama, K., Kikuchi, K., Ikeda, T., Kitajima, M., and Yamaguchi, K. (2001) Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues. Cancer Lett. 171, 103-110.
3. Maass, N., Teffner, M., Rosel, F., Pawaresch, R., Jonat, W., Nagasaki, K., and Rudolph, P. (2001) Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J. Pathol. 195, 321-326.
4. Yasumatsu, R., Nakashima, T., Hirakawa, N., Kumamoto, Y., Kuratomi, Y., Tomita, K., and Komiyama, S. (2001) Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck 23, 962-966.
5. Sheng, S., Carey, J., Seftor, E. A., Dias, L., Hendrix, M. J., and Sager, R. (1996) Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc. Natl. Acad. Sci. USA 93, 11669-11674.
6. Zhang, M., Volpert, O., Shi, Y. H., and Bouck, N. (2000) Maspin is an angiogenesis inhibitor. Nature Medicine 6, 196-199.
7. Andreasen, P. A., Kjoller, L., Christensen, L., and Duffy, M. J. (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72, 1-22.
8. Gettins, P. G. (2002) Serpin structure, mechanism, and function. Chem. Rev. 102, 4751-4804.
9. Sheng, S., Truong, B., Fredrickson, D., Wu, R., Pardee, A. B., and Sager, R. (1998). Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. Proc. Natl. Acad. Sci. USA 95, 499-504.
10. McGowen, R., Biliran, H., Jr., Sager, R., and Sheng, S. (2000) The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. Cancer Res. 60, 4771-4778.
11. Pemberton, P. A., Wong, D. T., Gibson, H. L., Kiefer, M. C., Fitzpatrick, P. A., Sager, R., and Barr, P. J. (1995) The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin. J. Biol. Chem. 270, 15832-15837.
12. Bass, R., Fernandez, A. M., and Ellis, V. (2002) Maspin inhibits cell migration in the absence of protease inhibitory activity. J. Biol. Chem. 277, 46845-46848.
13. Ngamkitidechakul, C., Warejcka, D. J., Burke, J. M., O'Brien, W. J., and Twining, S. S. (2003) Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule. J. Biol. Chem. 278, 31796-31806.
14. Al-Ayyoubi, M., Gettins, P. G., and Volz, K. (2004) Crystal structure of human maspin, a serpin with antitumor properties: reactive center loop of maspin is exposed but constrained. J. Biol. Chem. 279, 55540-55544.
15. Law, R. H., Irving, J. A., Buckle, A. M., Ruzyla, K., Buzza, M., Bashtannyk-Puhalovich, T. A., Beddoe, T. C., Nguyen, K., Worrall, D. M., Bottomley, S. P., Bird, P. I., Rossjohn, J., and Whisstock, J. C. (2005) The high resolution crystal structure of the human tumor suppressor maspin reveals a novel conformational switch in the G-helix. J. Biol. Chem. 280, 22356-22364.
16. Mohsin, S. K., Zhang, M., Clark, G. M., and Craig Allred, D. (2003) Maspin expression in invasive breast cancer: association with other prognostic factors. J. Pathol. 199, 432-435.
17. Sood, A. K., Fletcher, M. S., Gruman, L. M., Coffin, J. E., Jabbari, S., Khalkhali-Ellis, Z., Arbour, N., Seftor, E. A., and Hendrix, M. J. (2002) The paradoxical expression of maspin in ovarian carcinoma. Clin. Cancer Res. 8, 2924-2932.
18. Odero-Marah, V. A., Khalkhali-Ellis, Z., Schneider, G. B., Seftor, E. A., Seftor, R. E., Koland, J. G., and Hendrix, M. J. (2002) Tyrosine phosphorylation of maspin in normal mammary epithelia and breast cancer cells. Biochem. Biophys. Res. Commun. 295, 800-805.
19. Liu, J., Yin, S., Reddy, N., Spencer, C., and Sheng, S. (2004) Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res. 64, 1703-1711.
20. Chen, E. I., Florens, L., Axelrod, F. T., Monosov, E., Barbas, C. F., 3rd, Yates, J. R., 3rd, Felding-Habermann, B., and Smith, J. W. (2005) Maspin alters the carcinoma proteome. FASEB J. 19, 1123-1124.
21. Yin, S., Li, X., Meng, Y., Finley, R. L., Jr., Sakr, W., Yang, H., Reddy, N., and Sheng, S. (2005) Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione s-transferase. J. Biol. Chem. 280, 34985-34996.
22. Bailey, C. M., Khalkhali-Ellis, Z., Kondo, S., Margaryan, N. V., Seftor, R. E., Wheaton, W. W., Amir, S., Pins, M. R., Schutte, B. C., and Hendrix, M. J. (2005) Mammary serine protease inhibitor (maspin) binds directly to interferon regulatory factor 6: identification of a novel serpin partnership. J. Biol. Chem. 280, 34210-34217.
23. Liang, P., Averboukh, L., Keyomarsi, K., Sager, R., and Pardee, A. B. (1992) Differential display and cloning of messenger RNAs from human breast cancer verses mammary epithelial cells. Cancer Res. 52, 6966-6968.
24. Maass, N., Biallek, M., Rosel, F., Schem, C., Ohike, N., Zhang, M., Jonat, W., and Nagasaki, K. (2002) Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem. Biophys. Res. Comm. 297, 125-128.
25. Zhang, M., Shi, Y., Magit, D., Furth, P. A., and Sager, R. (2000) Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice. Oncogene 19, 6053-6058.
26. Pierson, C. R., McGowen, R., Grignon, D., Sakr, W., Dey, J., and Sheng, S. (2002) Maspin is up-regulated in premalignant prostate epithelia. Prostate 53, 255-262.
27. Chen, Z., Fan, Z., McNeal, J. E., Nolley, R., Caldwell, M. C., Mahadevappa, M., Zhang, Z., Warrington, J. A., and Stamey, T. A. (2003) Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer. J. Urol. 169, 1316-1319.
28. Gao, F., Shi, H. Y., Daughty, C., Cella, N., and Zhang, M. (2004) Maspin plays an essential role in early embryonic development. Development 131, 1479-1489.
29. Steller, H. (1995) Mechanisms and genes of cellular suicide. Science 267, 1445-1449.
30. Ellis, R. E., Yuan, J. Y., and Horvitz, H. R. (1991) Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7, 663-698.
31. Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70.
32. Townson, J. L., Naumov, G. N., and Chambers, A. F. (2003) The role of apoptosis in tumor progression and metastasis. Curr. Mol. Med. 3, 631-642.
33. Jiang, N., Meng, Y., Zhang, S., Mensah-Osman, E., and Sheng, S. (2002) Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 21, 4089-4098.
34. Latha, K., Zhang, W., Cella, N., Shi, H. Y., and Zhang, M. (2005) Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Mol. Cell Biol. 25, 1737-1748.
35. Schwartz, A. L., and Ciechanover, A. (1999) The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu. Rev. Med. 50, 57-74.